Diventiamo REALI: strumento di comunicazione sanitaria familiare nel trapianto di cellule staminali pediatriche e nella terapia cellulare
Diventiamo REALI: una sperimentazione pilota di uno strumento di comunicazione sanitaria familiare nel trapianto di cellule staminali pediatriche e nella terapia cellulare
The investigators will conduct a pilot feasibility and efficacy trial of a newly developed family health communication tool (called Let's Get REAL) in increasing youth involvement in real-time stem cell transplant and cellular therapy decisions (SCTCT). The investigators will pilot the intervention among 24 youth and their parents, stratified by youth age (stratum 1, 8-12 years of age and stratum 2, 13-17 years of age).
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Ginny L Schulz, Ph.D., RN, CPNP-PC
- Numero di telefono: 314-454-6018
- Email: schulz_g@wustl.edu
Luoghi di studio
-
-
Missouri
-
St Louis, Missouri, Stati Uniti, 63110
- Reclutamento
- Washington University School of Medicine
-
Sub-investigatore:
- Shalini Shenoy, M.D.
-
Contatto:
- Ginny L Schulz, Ph.D., RN, CPNP-PC
- Numero di telefono: 314-454-6018
- Email: schulz_g@wustl.edu
-
Investigatore principale:
- Ginny L Schulz, Ph.D., RN, CPNP-PC
-
Sub-investigatore:
- Amy McQueen, Ph.D.
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria Youth:
- Children or adolescents 8-17 years of age referred for SCTCT.
- Diagnosis of malignant or nonmalignant disorder.
- Referred for any type of SCTCT. Autologous and allogeneic stem cell and cellular therapies are eligible.
- Planning to meet with a provider to discuss SCTCT.
- Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed assent document.
- Must speak English and be cognitively able to participate.
Inclusion Criteria Parents:
- Parent or guardian of a child 8-17 years of age with any diagnosis referred for any type of SCTCT. Diagnoses may include malignant and nonmalignant disorders. Autologous and allogeneic stem cell and cellular therapies are eligible. Parent or guardian is defined as an adult who usually cares for the youth and has authority to make medical decisions for them.
- Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed consent document.
- Must speak English and be cognitively able to participate.
Exclusion Criteria Youth:
-
Active medical problems severe enough to preclude study participation at the time of recruitment.
- Patients who are otherwise eligible, but whose primary transplant physician does not want them to participate in the study.
-
Lacks cognitive capacity to complete study activities, as determined by consenting professional.
Exclusion Criteria Parents:
- Their youth referred for SCTCT does not assent to participate.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Ricerca sui servizi sanitari
- Assegnazione: Non randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Let's Get REAL family health communication tool: Patients (8-12 years of age)
Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation. |
Family health communication tool |
|
Sperimentale: Let's Get REAL family health communication tool: Patients (13-17 years of age)
Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation. |
Family health communication tool |
|
Sperimentale: Let's Get REAL family health communication tool: Parents
Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation. |
Family health communication tool |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Feasibility of intervention as measured by the Feasibility of Intervention questionnaire
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report feasibility of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater feasibility. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Acceptability of intervention as measured by the Acceptability of Intervention questionnaire
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report acceptability of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater acceptability. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Appropriateness of intervention as measured by the Intervention of Appropriateness questionnaire
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report appropriateness of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater appropriateness. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Feasibility of intervention as measured qualitatively
Lasso di tempo: Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of feasibility content codes. |
Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
|
Acceptability of intervention as measured qualitatively
Lasso di tempo: Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of acceptability content codes. |
Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
|
Appropriateness of intervention as measured qualitatively
Lasso di tempo: Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of appropriateness content codes. |
Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Numero di pazienti che hanno scelto SCTCT
Lasso di tempo: Fino a 4 settimane dopo la consultazione SCTCT (stimata alla settimana 8)
|
Fino a 4 settimane dopo la consultazione SCTCT (stimata alla settimana 8)
|
|
|
Difference in feasibility scores in those 8-12 years of age and those 13-17 years of age as measured by the Feasibility of Intervention questionnaire
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report feasibility of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater feasibility. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Difference in acceptability scores in those 8-12 years of age and those 13-17 years of age as measured by the Acceptability of Intervention questionnaire
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report acceptability of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater acceptability. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Difference in appropriateness scores in those 8-12 years of age and those 13-17 years of age as measured by the Intervention of Appropriateness questionnaire
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report appropriateness of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater appropriateness. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Perceived levels of decision-making involvement in youth 8-17 years of age and their parents as measured by the Decision Making Involvement Scale
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 30-item scale that youth and their parents report youth involvement behaviors in a decision related to their illness on a 4-point Likert scale ranging from 'A Little Bit' to 'A Lot'. The higher the subscale score (child seek, child express, parent seek, parent express, and joint/options), the more that behavior or type of involvement occurred in the decision making process. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Observed levels of decision-making involvement in youth 8-17 years of age and their parents
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
Number of utterance occurrences for the following: 1) who uttered (youth, parent), 2) was utterance prompted (yes/no), if so, by who, 3) type of utterance (questions, opinion, concern, other), and 4) content of utterance (prognosis, side effect, expectation). |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Change in youth-parent communication as measured by the Likert-type Parent-Adolescent Communication Scale
Lasso di tempo: Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
This is a 20-item scale that youth and parents report the degree of openness in family communication and the extent of problems with family communications on a 5-point Likert ranging from 'strongly disagree' to 'strongly agree'. A higher score on the degree of openness subscale indicates better communication between parent and adolescent. For extent of problems subscale, a higher score indicates more problems in the parent-child communication. |
Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
|
Change in the level of youth's general anxiety as measured by the Likert-type PROMIS Anxiety 8a Short Form or parent proxy
Lasso di tempo: Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
This is an 8-item scale that measures youth's general anxiety in those 8-17 years of age on a 5-point Likert scale ranging from 'never' to 'almost always'. |
Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
|
Level of decisional conflict as measured by the Likert-type Decisional Conflict Scale
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 10-item scale that youth and parents report their personal uncertainty and decisional conflict related to a specific decision. We are using the question format as it is recommended for those with limited reading or response skills. They respond 'Yes', 'No, or 'Unsure'. A total decision conflict score ranges from 0 (no decisional conflict) to 100 (extremely high decision conflict). Higher scores on subscales uncertainty, informed, values clarity, and support reflect feeling extremely uncertain about the best choice, feeling extremely uninformed, feeling extremely unclear about personal values, and feeling extremely unsupported in decision making respectively. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Youth-parent congruence of youth decision making involvement as measured by two Likert type statements
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
Number of dyads that agree on these two statements measured on a 4-point Likert scale ranging from 'Not at all' to 'A lot': 1)"I/my child should be involved in future talks about transplant" and 2) "I/my child wants to be involved in future talks about transplant". |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Satisfaction with the decision making involvement as measured by one Likert type statement
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a one item statement, "I am satisfied with my/my child's involvement in the transplant decision making process", measured on a 4-point Likert scale ranging from 'Not at all' to 'A lot'. A higher score indicates more satisfaction. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
Collaboratori e investigatori
Sponsor
Sponsor
Collaboratori
Collaboratori
Investigatori
Investigatori
- Investigatore principale: Ginny Schulz, Ph.D., RN, CPNP-PC, Washington University School of Medicine
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
- Disturbi da insufficienza del midollo osseo
- Neoplasie per sede
- Neoplasie
- Malattie genetiche, congenite
- Malattie del sistema immunitario
- Malattie ematologiche
- Malattie del midollo osseo
- Anemia, emolitica, congenita
- Anemia, emolitico
- Anemia
- Emoglobinopatie
- Malattie e anomalie congenite, ereditarie e neonatali
- Malattie nutrizionali e metaboliche
- Malattie emiche e linfatiche
- Neoplasie ematologiche
- Anemia, anemia falciforme
- Sindromi da deficit immunologico
- Malattie metaboliche
- Anemia, aplastica
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- 202410119
- K12CA167540 (Sovvenzione/contratto NIH degli Stati Uniti)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .